Study of the Use of a Single Dose of Erythropoietin to Treat Acute Myocardial Ischemia

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

January 31, 2011

Study Completion Date

April 30, 2011

Conditions
CABGCoronary Artery Disease
Interventions
DRUG

Epoetin alpha

A single dose of epoetin alpha during CABG for three vessel disease, 60.000 IU intravenously.

DRUG

NaCl 0.9%

A single dose of NaCl 0.9% during CABG for three vessel disease, 1 ml intravenously.

Trial Locations (1)

9700 BD

University Medical Center Groningen, Dept. of Cardiology, Groningen

All Listed Sponsors
lead

University Medical Center Groningen

OTHER

NCT00524901 - Study of the Use of a Single Dose of Erythropoietin to Treat Acute Myocardial Ischemia | Biotech Hunter | Biotech Hunter